Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
12:30:28 EDT Fri 06 Jun 2025
Enter Symbol
or Name
USA
CA



Q:ELTP - ELITE PHARMACEUTICALS INC - https://www.elitepharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
ELTP - Qnot subscribed0.5799+0.023334.21,183.76562260.57  0.58  0.5594250.7549  0.16212:12:34Apr 3015 min RT 2¢

Recent Trades - Last 10 of 226
Time ETExPriceChangeVolume
12:12:34Q0.57990.023336,593
12:12:33Q0.57990.023335,000
12:10:49Q0.5790.0224329
12:09:17Q0.57990.023331,000
12:09:16Q0.57990.023331,000
12:09:03Q0.579450.022886,802
12:08:44Q0.579090.0225250
12:06:51Q0.57990.023333,500
12:06:48Q0.579450.022881,500
12:04:32Q0.57990.0233315

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-04-30 16:31U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets
2025-03-03 07:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line
2025-02-13 16:23U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information
2025-02-10 16:55U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025
2024-12-26 07:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)
2024-12-02 06:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets
2024-11-18 06:01U:ELTPNews ReleaseElite Pharmaceuticals Receives FDA Approval for Generic Vyvanse
2024-11-14 16:39U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information
2024-11-07 07:02U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024
2024-10-10 16:42U:ELTPNews ReleaseElite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health
2024-10-07 07:31U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Codeine Phosphate Tablets
2024-08-27 07:01U:ELTPNews ReleaseElite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium
2024-08-14 17:10U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information
2024-08-09 16:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024
2024-07-01 17:08U:ELTPNews ReleaseElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information
2024-06-26 15:01U:ELTPNews ReleaseElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024